These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12203139)

  • 61. Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML.
    Schleuning M; Günther W; Tischer J; Ledderose G; Kolb HJ
    Bone Marrow Transplant; 2003 Aug; 32(3):243-50. PubMed ID: 12858194
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Allogeneic bone marrow transplantation for infants with acute leukemia or myelodysplastic syndrome.
    Leung W; Pitts N; Burnette K; Cunningham JM; Horwitz EM; Benaim E; Hale G; Woodard P; Pui CH; Bowman LC
    Bone Marrow Transplant; 2001 Apr; 27(7):717-22. PubMed ID: 11360111
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Second allogeneic bone marrow transplantation after myeloablative conditioning analysis of 43 cases from single institution.
    Al-Qurashi F; Ayas M; Al Sharif F; Ibrahim E; Sahovic E; Al Mahr M; Chaudhri N; Al Mohareb F; Al Zahrani H; Al Jefri A; Al Omar H; Al Shanqeeti A; Seth P; Aslam M; El Solh H; Aljurf M
    Hematology; 2004 Apr; 9(2):123-9. PubMed ID: 15203867
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Successful high-dose chemotherapy combined with autologous bone marrow transplantation in a case of refractory follicular lymphoma].
    Nagai T; Hirayama Y; Ohta H; Koyama R; Matsunaga T; Kuga T; Sakamaki S; Niitsu Y
    Rinsho Ketsueki; 1997 Jun; 38(6):513-9. PubMed ID: 9248327
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Foscarnet prophylaxis of cytomegalovirus infections in patients undergoing allogeneic bone marrow transplantation (BMT): a dose-finding study.
    Bregante S; Bertilson S; Tedone E; Van Lint MT; Trespi G; Mordini N; Berisso G; Gualandi F; Lamparelli T; Figari O; Benvenuto F; Raiola AM; Bacigalupo A
    Bone Marrow Transplant; 2000 Jul; 26(1):23-9. PubMed ID: 10918402
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Allogeneic bone marrow transplantation with reduced conditioning (RC-BMT).
    Vindeløv L
    Eur J Haematol; 2001 Feb; 66(2):73-82. PubMed ID: 11168513
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: cryptic etiology and uncertain therapy.
    Lewis ID; DeFor T; Weisdorf DJ
    Bone Marrow Transplant; 2000 Sep; 26(5):539-43. PubMed ID: 11019844
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pulmonary function changes 100 days and one year after bone marrow transplantation.
    Badier M; Guillot C; Delpierre S; Vanuxem P; Blaise D; Maraninchi D
    Bone Marrow Transplant; 1993 Nov; 12(5):457-61. PubMed ID: 8298556
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission.
    Brown JR; Feng Y; Gribben JG; Neuberg D; Fisher DC; Mauch P; Nadler LM; Freedman AS
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1057-65. PubMed ID: 17697968
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Allogeneic bone marrow transplantation for childhood relapsed acute lymphoblastic leukemia: comparison of outcome in patients with and without a matched family donor.
    Bleakley M; Shaw PJ; Nielsen JM
    Bone Marrow Transplant; 2002 Jul; 30(1):1-7. PubMed ID: 12105770
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Reduced intensity conditioning HLA identical sibling donor allogeneic stem cell transplantation for patients with follicular lymphoma: long-term follow-up from two prospective multicenter trials.
    Piñana JL; Martino R; Gayoso J; Sureda A; de la Serna J; Díez-Martín JL; Vazquez L; Arranz R; Tomás JF; Sampol A; Solano C; Delgado J; Sierra J; Caballero D;
    Haematologica; 2010 Jul; 95(7):1176-82. PubMed ID: 20107156
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Bone marrow transplantation in children with neuroblastoma.
    Dopfer R; Berthold F; Einsele H; Ehninger G; Klingebiel T; Handgretinger R; Bruchelt G; Niethammer D; Stollmann B; Rister M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):427-36. PubMed ID: 2480285
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Autologous hematopoietic stem cell transplantation for relapsed follicular lymphoma: safety profile and clinical outcome in a single-center experience.
    Helbig G; Krawczyk-Kulis M; Kopinska A; Liwoch R; Kyrcz-Krzemien S
    Med Oncol; 2014 Dec; 31(12):310. PubMed ID: 25373321
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Successful engraftment of a second transplant using non-myeloablative conditioning as treatment for graft failure following unrelated donor BMT.
    Byrne JL; Musuka C; Davy B; Donovan L; Russell NH
    Bone Marrow Transplant; 2001 Mar; 27(5):547-9. PubMed ID: 11313691
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Histologic transformation of follicular lymphoma after allogeneic bone marrow transplantation.
    Kojima K; Mannami T; Yoshino T; Kawasaki H; Sasaki K; Maeda T; Furuya K; Harada M; Hara M
    Bone Marrow Transplant; 2000 Sep; 26(5):581-3. PubMed ID: 11019852
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital.
    Grow WB; Moreb JS; Roque D; Manion K; Leather H; Reddy V; Khan SA; Finiewicz KJ; Nguyen H; Clancy CJ; Mehta PS; Wingard JR
    Bone Marrow Transplant; 2002 Jan; 29(1):15-9. PubMed ID: 11840139
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma.
    Verdonck LF; Dekker AW; Lokhorst HM; Petersen EJ; Nieuwenhuis HK
    Blood; 1997 Nov; 90(10):4201-5. PubMed ID: 9354692
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients-report of the French society of bone marrow transplantation.
    Yakoub-Agha I; de La Salmonière P; Ribaud P; Sutton L; Wattel E; Kuentz M; Jouet JP; Marit G; Milpied N; Deconinck E; Gratecos N; Leporrier M; Chabbert I; Caillot D; Damaj G; Dauriac C; Dreyfus F; François S; Molina L; Tanguy ML; Chevret S; Gluckman E
    J Clin Oncol; 2000 Mar; 18(5):963-71. PubMed ID: 10694545
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Intravesical rhGM-CSF for the treatment of late onset hemorrhagic cystitis after bone marrow transplant.
    Vela-Ojeda J; Tripp-Villanueva F; Sanchez-Cortés E; Ayala-Sanchez M; García-Ruiz Esparza MA; Rosas-Cabral A; Gonzalez-Llaven J
    Bone Marrow Transplant; 1999 Dec; 24(12):1307-10. PubMed ID: 10627639
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Successful allogeneic bone marrow transplantation in selected patients over 50 years of age--a single institution's experience.
    Du W; Dansey R; Abella EM; Baynes R; Peters WP; Klein J; Akhtar A; Cherednikova L; Karanes C
    Bone Marrow Transplant; 1998 May; 21(10):1043-7. PubMed ID: 9632279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.